An improved HPLC method for determination of colocynthin in colocynth

Document Type: Original paper


1 Food and Drug Control Laboratories and Food and Drug Laboratory Research Center, MOH and ME, Tehran, Iran.

2 Department of Traditional Pharmacy, Faculty of Traditional Medicine, Tehran University of Medical Sciences, Tehran, Iran. Institute of Environmental Research (INFU) of the Faculty of Chemistry, TU Dortmund, Otto-Hahn-Str. 6, D-44221 Dortmund, Germany.

3 Department of Pharmacognosy, Faculty of Pharmacy and Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran.

4 Institute of Environmental Research (INFU) of the Faculty of Chemistry, TU Dortmund, Otto-Hahn-Str. 6, D-44221 Dortmund, Germany.

5 Department of Pharmacognosy, Faculty of Pharmacy and Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran. Faculty of Land and Food Systems, University of British Columbia, Vancouver, BC, Canada.


Background and objectives: Colocynthin is the major active secondary metabolite of colocynth, Citrullus colocynthis (L.) Schrad, which has been used in traditional and ethno medicine of many countries.  It could be considered as an active marker for quality control of colocynth and its herbal products. Analysis and standardization of colocynth and its herbal preparations are a critical issue for their safe applications in phytotherapy and traditional medicine. In the present work, a simple and efficient sample preparation was developed and optimized through combination of matrix solid phase dispersion and ultrasonic assisted extraction. In addition, analytical reversed-phase HPLC method was optimized for analyzing the concentration of colocynthin in colocynth pulp. Methods: Powdered colocynth pulp was grinded with diatomaceous earth to obtain a homogenous mixture. The blend was mixed with methanol and extracted by sonication, followed by centrifugation and filtration. The analytical chromatographic separation was carried out using Luna C18 in isocratic elution with methanol: isopropanol: water: triflouroacetic acid (30:10:60:0.1 v/v). The method was validated as well.  Results: The validation parameters were determines as follows, linear range (r2 = 0.999, 75-500 μg/mL), precision (intra-day < 2.7%, inter-day = 4.4%) and accuracy measured via determination of recovery (90-107%). The limit of detection and quantization were calculated 8.5 and 25.7 μg/mL, respectively. Conclusion: Regarding the relatively high content of colocynthin in colocynth pulp, the validated HPLC method could be applied for quality control of colocynth pulp used in Traditional Persian Medicine.  


Khafagi I, Zakaria A, Dewedar A, El-Zahdany K. A voyage in the world of plants as mentioned in the Holy Quran. Int J Botany. 2006; 2(3): 242-251.

[2]  Aghili Khorasani MH. Monographs. In: Shams Ardakani MR, Rahimi R, Farjadmand F, eds. Makhzan ol Advieh (Drugs Resevoir). Tehran: Tehran University of Medical Sciences Press, 2009.

[3]  Memon U, Brohi AH, Ahmed SW, Azhar I, Bano H. Antibacterial screening of Citrullus colocynthis. Pak J Pharm Sci. 2003; 16(1): 1-6.

[4]  Jayaraman R, Shivakumar A, Anitha T, Joshi VD, Palei NN. Antidiabetic effect of petroleum ether extract of Citrullus colocynthis fruits against streptozotocin-induced hyperglycemic rats. Rom J Biol Plant Biol. 2009; 54(2): 127-134.

[5]  Asad MH, Razi MT, Murtaza G, Azhar S, Khan SA, Saqib QN, Hussain I. Antihaemorrhagic potential of Citrullus colocynthis Schrad (Cucurbitaceae) against Naja naja karachiensis (black pakistan cobra) Venom. J Med Plants Res. 2012; 6(18): 3455-3458.

[6]  Aly AM, Naddaf A. Anti-inflammatory activities of colocynth topical gel. J Med Sci. 2006; 6(2): 216-221.

[7]Yoshikawa M, Morikawa T, Kobayashi H, Nakamura A, Matsuhira K, Nakamura S, Hisashi Matsuda H. Bioactive saponins and glycosides. XXVII. Structures of new cucurbitane-type triterpene glycosides and antiallergic constituents from Citrullus colocynthis. Chem Pharm Bul. 2007; 55(3): 428-434.

[8]  Khoshvaghti A, Hamidi AR. Comparative effects of oral administration of Citrullus colocynthis and insulin injection on serum parameters of alloxan-induced diabetic dogs. Comp Clin Pathol. 2011; 8(11): 1-5.

[9]  Dallak M, Bashir N, Abbas M, Elessa R, Haidara M, Khalil M, Al-Khateeb MA. Concomitant down regulation of glycolytic enzymes, upregulation of gluconeogenic enzymes and potential hepato-nephro-protective effects following the chronic administration of the hypoglycemic, insulinotropic Citrullus colocynthis pulp extract. Am J Biochem Biotechnol. 2009; 5(4): 153-161.

[10]Khalil M, Mohamed G, Dallak M. The effect of Citrullus colocynthis pulp extract on the liver of diabetic rats a light and scanning electron microscopic study. Am J Biochem Biotechnology. 2010; 6(3): 155-163.

[11]Rajamanickam E, Gurudeeban S, Ramanathan T, Satyavani K. Evaluation of anti-inflammatory activity of Citrullus colocynthis. Int J Curt Res. 2010; 2: 67-69.

[12]Tannin-Spitz T, Grossman S, Dovrat S, Gottlieb HE, Bergman M. Growth inhibitory activity of cucurbitacin glucosides isolated from Citrullus colocynthis on human breastcancer cells. Biochem Pharmacol. 2007; 73(1): 56-67.

[13]Abdel-Hassan IA, Abdel-Barry JA, Mohammeda ST. The hypoglycaemic and antihyperglycaemic effect of Citrullus colocynthis fruit aqueous extract in normal and alloxan diabetic rabbits. J Ethnopharmacol. 2000; 71(1): 325-330.

[14]Daradka H, Almasad MM, Qazan WS, El-Banna NM, Samara OH. Hypolipidemic effects of Citrullus colocynthis L. in rabbits. Pak J Biomed Sci. 2007; 10(16): 2768-2771.

[15]Dallak M. In vivo, hypolipidemic and antioxidant effects of Citrullus colocynthis pulp extract in alloxan-induced diabetic rats. Afr J Biotechnol. 2011; 10(48): 9898-9903.

[16]Mali PC, Chaturvedi M, Ansari AS. Induction of reversible antifertility with a crude ethanol extract of Citrullus colocynthis Schrad fruit in male rats. Pharmacology. 2003; 68: 38-48.

[17]Nmila R, Gross R, Rchid H, Roye M, Manteghetti M, Petit P, Tijane M, Ribes G, Sauvaire Y. Insulinotropic effect of Citrullus colocynthis fruit extracts. Planta Med. 2000; 66(5): 418-423.

[18]Almeida RN, Navarro DS, Barbosa-Filho JM. Plants with central analgesic activity. Phytomedicine. 2001; 8(4): 310-322.

[19]Atole S, Jangde C, Philip P, Rekhe D, Aghav D, Waghode H, Chougule A. Safety evaluation studies of Citrullus colocynthis for diabetes in rats. Vet World. 2009; 2(11): 423-425.

[20]Fallah Huseini H, Darvishzadeh F, Heshmat R, Jafariazar Z, Raza M, Larijani B. The clinical investigation of Citrullus colocynthis (L.) Schrad fruit in treatment of type II diabetic patients: A randomized, double blind, placebo-controlled clinical trial. Phytother Res. 2009; 23: 1186-1189.

[21]Rahbar AR, Nabipour I. The hypolipidemic effect of Citrullus colocynthis on patients with hyperlipidemia. Pak J Biol Sci. 2010; 13(24):1202-1207.

[22]Lorenz PR, Lippmann F, Dürrling K, Solf M, Geissler G. Pharmaco-toxicological and clinical studies with colocynth pulp extracts (extr. colocynthidis fructus). Arzneimittel Forsch. 2005; 55(11): 621-663.

 [23]Delazar A, Gibbons S, Kosari A, Nazemiyeh H, Modarresi M, Nahar L, Sarker SD. Flavone c-glycosides and cucurbitacin glycosides from Citrullus colocynthis. Daru J pharmaceut sci. 2006; 14(3): 109-114.

[24]Jing M, Jie Z, Shi-ming D, Bin D. A new flavone c-glycoside from Citrullus colocynthis. China Herb Med. 2012; 4(1): 1-3.

[25]Salama HM. Alkaloids and flavonoids from the air dried aerial parts of Citrullus colocynthis. J Med Plants Res. October 3 2012; 6(38): 5150-5155.

[26] Darvish-Sayed M, Balbaa SI, Afifi MS. Nitrogenous bases of the different organs of Citrullus colocynthis. Planta Med. 1973; 24(7): 260-265.

[27]Power FB, Moore CW. XII. The constituents of colocynth. J Chem Soc Trans. 1910; 97(0): 99-110.

[28]Jewell R. Colocynth. In: Enna SJ, Bylund DB, Ed. xPharm: The comprehensive pharmacology reference. Amesterdam: Elsevier, 2011.

[29]Banerjee SP, Dandiya PC. Smooth muscle and cardiovascular pharmacology of α-elaterin-2-D-glucopyranoside glycoside of Citrullus colocynthis. J Pharm Sci. 1967; 56(12): 1665-1667.

[30]European Medicines Agency. Reflection paper on markers used for quantitative and qualitative analysis of herbal medicinal products and traditional herbal medicinal products. London: European Medicines Agency, 2008.

[31]Bauer R, Wagner H. Cucurbitacinhaltige drogen. Analyse und standardisierung von arzneidrogen und phytopreparaten durch hochleistungs flüssig chromoatgraphie (HPLC) und andere chromatographische verfahren (II). Deutsche Apoth Zeitung. 1983; 123(27): 1313-1321.

[32]Halaweish FT, Tallamy DW. Quantitative determination of cucurbitacins by High Performance Liquid Chromatography and High Performance Thin Layer Chromatography. J Liq Chromatogr. 1993; 16(2): 497-511.

[33]Matsuo K, DeMilo AB, Schroder RF, Martin PA. Rapid High-Performance Liquid Chromatography method to quantitate elaterinide in juice and reconstituted residues from a bitter mutant of hawkesbury watermelon. J Agric Food Chem. 1999; 47: 2755-2759.

[34]Khadem H, Abdel Rahman MM. Constituents of the fruit of Citrullus colocynthis. J Chem Soc. 1963; 4: 4991-4993.

[35]Sachdev-Gupta K, Radke CD, Renwick JAA. Antifeedant activity of cucurbitacins from Iberis amara against larvae of Pieris rapae. Phytochemistry. 1993; 33(6): 1385-1388.

[36]Seger C, Sturm S, Mair M-E, Ellmerer EP, Stuppner H. 1H and 13C NMR signal assignment of cucurbitacin derivatives from Citrullus colocynthis (L.) Schrader and Ecballium elaterium L. (Cucurbitaceae). Magn Reson Chem. 2005; 43: 489-491.

[37]Hatam NA, Whiting DA, Yousif NJ. Cucurbitacin glycosides from Citrullus colocynthis. Phytochemistry. 1989; 28(4): 1268-1271.

[38]Waksmundzka-Hajnos M, Sherma J. High performance liquid chromatography in phytochemical analysis. New York: CRC Press, 2011.

[39]Capriotti AL, Cavaliere C, Giansanti P, Gubbiotti R, Samperi R, Lagana A. Recent developments in matrix solid-phase dispersion extraction. J Chromatogr A. 2010; 1217: 2521-2532.

[40]Capriotti AL, Cavaliere C, Lagana A, Piovesana S, Samperi R. Recent trends in matrix solid-phase dispersion. Trac-Trend Anal Chem. 2013; 43: 53-66.

[41]Shekarchi M, Hajimehdipoor H, Khanavi M, Adib N, Bozorgi M, Akbari-Adergani B. A validated method for analysis of Swerchirin in Swertia longifolia Boiss. by high performance liquid chromatography. Pharmacogn Mag. 2010; 6(21): 13-18.

[42]Hajimehdipoor H, Shekarchi M, Khanavi M, Adib N, Amri M. A validated high performance liquid chromatography method for the analysis of thymol and carvacrol in Thymus vulgaris L. volatile oil. Pharmacogn Mag. 2010; 6(23): 154-158.

[43] International         conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH). ICH harmonized tripartite guideline, validation of analytical procedures: text and methodology Q2(R1),  1994-2005. Geneve: ICH, 2005.

[44]Unger KK, Weber E. A guide to practical HPLC. Darmstadt: GIT Verlag, 1999.

[45]Masson P. Quality control techniques for routine analysis with liquid chromatography in laboratories. J Chromatogr A .2007; 1158(1): 168-173.

[46]Food and Drug Administration  (FDA). Guidance for industry: bioanalytical method validation. Washington DC: FDA, 2001.